Exploring the Molecular Tumor Microenvironment and Translational Biomarkers in Brain Metastases of Non-Small-Cell Lung Cancer
Open Access
- 7 February 2024
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (4) , 2044
Abstract
Brain metastases represent a significant clinical challenge in the treatment of non-small-cell lung cancer (NSCLC), often leading to a severe decline in patient prognosis and survival. Recent advances in imaging and systemic treatments have increased the detection rates of brain metastases, yet clinical outcomes remain dismal due to the complexity of the metastatic tumor microenvironment (TME) and the lack of specific biomarkers for early detection and targeted therapy. The intricate interplay between NSCLC tumor cells and the surrounding TME in brain metastases is pivotal, influencing tumor progression, immune evasion, and response to therapy. This underscores the necessity for a deeper understanding of the molecular underpinnings of brain metastases, tumor microenvironment, and the identification of actionable biomarkers that can inform multimodal treatment approaches. The goal of this review is to synthesize current insights into the TME and elucidate molecular mechanisms in NSCLC brain metastases. Furthermore, we will explore the promising horizon of emerging biomarkers, both tissue- and liquid-based, that hold the potential to radically transform the treatment strategies and the enhancement of patient outcomes.Keywords
This publication has 172 references indexed in Scilit:
- Cerebrospinal fluid circulating tumor DNA depicts profiling of brain metastasis in NSCLCMolecular Oncology, 2022
- Use of radiomics based on 18F-FDG PET/CT and machine learning methods to aid clinical decision-making in the classification of solitary pulmonary lesions: an innovative approachEuropean Journal of Nuclear Medicine and Molecular Imaging, 2021
- Comparative analysis of the tumor immune-microenvironment of primary and brain metastases of non-small-cell lung cancer reveals organ-specific and EGFR mutation-dependent unique immune landscapeCancer Immunology, Immunotherapy, 2021
- Development and validation of a five‐gene model to predict postoperative brain metastasis in operable lung adenocarcinomaInternational Journal of Cancer, 2020
- Driver genes as predictive indicators of brain metastasis in patients with advanced NSCLC: EGFR, ALK, and RET gene mutationsCancer Medicine, 2019
- Tumor-induced peripheral immunosuppression promotes brain metastasis in patients with non-small cell lung cancerCancer Immunology, Immunotherapy, 2019
- The biological functions and clinical applications of exosomes in lung cancerCellular and Molecular Life Sciences, 2019
- Genes associated with increased brain metastasis risk in non–small cell lung cancer: Comprehensive genomic profiling of 61 resected brain metastases versus primary non–small cell lung cancer (Guangdong Association Study of Thoracic Oncology 1036)Cancer, 2019
- Estimating Survival in Patients With Lung Cancer and Brain MetastasesJAMA Oncology, 2017
- Gram negative bacteria increase non‐small cell lung cancer metastasis via toll‐like receptor 4 activation and mitogen‐activated protein kinase phosphorylationInternational Journal of Cancer, 2014